-
Cambridge Company's Newly Approved ALS Drug Offers Hope for Families
A Cambridge company has won approval for a new drug to treat ALS. For many families, it brings a new sense of hope. The new drug from Cambridge-based Amylyx Pharmaceuticals Inc. is called Relyvrio. “People with ALS are some of the most strong and incredible people,” said Joshua Cohen, co-CEO and cofounder of Amylyx pharmaceuticals. Cohen and Justin Klee...
-
FDA Approves New ALS Drug Made by Company in Cambridge
The FDA approved the drug based on results from a small, mid-stage study where ALS patients appeared to progress more slowly and survive several months longer.
-
Decision on FDA Approval Expected for ALS Drug
The drug could potentially be a gamechanger in the battle against ALS by extending the lives of people with the condition.
-
Zac Brown Band's John Driskell Hopkins Shares ALS Diagnosis
The bassist for the Zac Brown Band announced he has been diagnosed with ALS.
-
FDA Panel Narrowly Sides Against Experimental ALS Drug
U.S. health advisers have narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig’s disease
-
FDA Skeptical of Benefits From Experimental ALS Drug
The Food and Drug Administration has issued a negative review of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease
-
Biden Signs Bills on Forced Labor in China, ALS Research
President Joe Biden has signed a bill into law to block imports from China’s Xinjiang region unless businesses can prove the items were made without using forced labor
Trending
